Vice President, Head of Chemical Sciences at Blueprint Medicines - Cambridge, MA, US
Director, Commercial Data Management & Operations
Blueprint Medicines develops kinase inhibitors for genomically defined cancer subsets of precision therapies, designed to allow patients to live longer and healthier lives.